1-3 of 3
Diederik van Bodegom, PhD
Close
Sort by
Journal Articles

Newer-Generation HSP90 Inhibitors Can Overcome Ibrutinib Resistance and Suppress Proliferation in Human Mantle Cell Lymphoma in Vitro and in Vivo

Nadja Kopp, MA, Sebastian Tschuri, Sarah Haebe, Diederik van Bodegom, PhD, Liat Bird, Amanda L. Christie, Amy Saur, Alexandra N. Christodoulou, Trevor Tivey, Andrew L Kung, MD PhD, Oliver Weigert, MD, David Weinstock, MD
Journal: Blood
Blood (2014) 124 (21): 1686.
https://doi.org/10.1182/blood.V124.21.1686.1686
Published: 2014
Journal Articles

Newer-Generation HSP90 Inhibitors Have Potent Activity Against Human Mantle Cell Lymphoma in Vitro and in Vivo

Oliver Weigert, MD, Diederik van Bodegom, PhD, Liat Bird, Amy Saur, Trevor Tivey, Nadja Kopp, Andrew L. Kung, MD, PhD, David Weinstock, MD
Journal: Blood
Blood (2012) 120 (21): 1651.
https://doi.org/10.1182/blood.V120.21.1651.1651
Published: 2012
Journal Articles

Trisomy of the Down Syndrome Critical Region Suppresses Precursor B-Cell Differentiation and Promotes B-Cell Transformation Associated with Altered Expression of Polycomb Repressor Complex 2 Targets

Andrew A. Lane, MD, PhD, Diederik van Bodegom, PhD, Bjoern Chapuy, MD, PhD, Gabriela Alexe, PhD, Timothy J Sullivan, PhD, Trevor Tivey, Tovah Day, PhD, John Crispino, PhD, Edward Fox, PhD, Kimberly Stegmaier, MD, David Weinstock, MD
Journal: Blood
Blood (2012) 120 (21): 115.
https://doi.org/10.1182/blood.V120.21.115.115
Published: 2012